down arrow

Fuso Pharmaceutical Industries Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3823600006
  • TKS: 4538
JPY
2,241.00
-24 (-1.06%)

Sep 24

TKS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
16,046.00
14,042.00
17,036.00
15,726.00
15,503.00
13,904.00
16,920.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
16,046.00
14,042.00
17,036.00
15,726.00
15,503.00
13,904.00
16,920.00
Raw Material Cost
11,848.00
10,570.00
12,617.00
11,701.00
11,424.00
10,022.00
12,652.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
104.00
102.00
80.00
76.00
70.00
50.00
39.00
Selling and Distribution Expenses
3,225.00
3,201.00
3,297.00
3,375.00
3,482.00
3,385.00
3,069.00
Other Expenses
-10.40
-10.20
-8.00
-7.60
-7.00
-5.00
-3.90
Total Expenditure (Excl Depreciation)
15,073.00
13,771.00
15,914.00
15,076.00
14,906.00
13,407.00
15,721.00
Operating Profit (PBDIT) excl Other Income
973
271
1122
650
597
497
1199
Other Income
-38.00
-39.00
163.00
-121.00
43.00
-8.00
35.00
Operating Profit (PBDIT)
1,588.00
737.00
1,953.00
1,184.00
1,281.00
563.00
1,825.00
Interest
104.00
102.00
80.00
76.00
70.00
50.00
39.00
Exceptional Items
82.00
3.00
0.00
4.00
77.00
-8,743.00
2.00
Gross Profit (PBDT)
4,198.00
3,472.00
4,419.00
4,025.00
4,079.00
3,882.00
4,268.00
Depreciation
653.00
505.00
668.00
655.00
641.00
74.00
591.00
Profit Before Tax
911.00
132.00
1,204.00
455.00
647.00
-8,304.00
1,198.00
Tax
268.00
-195.00
351.00
86.00
184.00
-2,613.00
331.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
642.00
327.00
853.00
369.00
462.00
-5,690.00
867.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
642.00
327.00
853.00
369.00
462.00
-5,690.00
867.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
642.00
327.00
853.00
369.00
462.00
-5,690.00
867.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
35,751.00
35,057.00
34,655.00
34,008.00
33,178.00
33,043.00
38,713.00
Earnings per share (EPS)
75.21
38.3
99.91
43.22
54.1
-666.25
101.5
Diluted Earnings per share
75.21
38.3
99.91
43.22
54.1
-666.25
101.5
Operating Profit Margin (Excl OI)
6.06%
1.93%
6.59%
4.13%
3.85%
3.57%
7.09%
Gross Profit Margin
9.75%
4.54%
10.99%
7.06%
8.31%
-59.19%
10.57%
PAT Margin
4.0%
2.33%
5.01%
2.35%
2.98%
-40.92%
5.12%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is 3.50% vs 6.03% in Jun 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2026 is 38.96% vs -26.90% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 31.34% vs -28.36% in Jun 2025

stock-summary

Interest

YoY Growth in quarter ended Jun 2026 is 48.57% vs 84.21% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Compare Quarterly Results Of Fuso Pharmaceutical Industries Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
16,046.00
0.00
16,046.00
Other Operating Income
0.00
0.00
0.00
Total Operating income
16,046.00
0.00
16,046.00
Raw Material Cost
11,848.00
0.00
11,848.00
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
104.00
0.00
104.00
Selling and Distribution Expenses
3,225.00
110.73
3,114.27
2,812.49%
Other Expenses
-10.40
10.72
-21.12
-197.01%
Total Expenditure (Excl Depreciation)
15,073.00
217.96
14,855.04
6,815.49%
Operating Profit (PBDIT) excl Other Income
973.00
-217.96
1,190.96
546.41%
Other Income
-38.00
-0.02
-37.98
-189,900.00%
Operating Profit (PBDIT)
1,588.00
-217.98
1,805.98
828.51%
Interest
104.00
0.00
104.00
Exceptional Items
82.00
0.00
82.00
Gross Profit (PBDT)
4,198.00
0.00
4,198.00
Depreciation
653.00
0.00
653.00
Profit Before Tax
911.00
-217.98
1,128.98
517.93%
Tax
268.00
0.60
267.40
44,566.67%
Provisions and contingencies
0
0
0.00
Profit After Tax
642.00
-218.58
860.58
393.71%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
642.00
-218.58
860.58
393.71%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
642.00
-218.58
860.58
393.71%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
35,751.00
3,574.53
32,176.47
900.16%
Earnings per share (EPS)
75.21
-5.04
80.25
1,592.26%
Diluted Earnings per share
75.21
-5.04
80.25
1,592.26%
Operating Profit Margin (Excl OI)
6.06%
0.00%
0.00
6.06%
Gross Profit Margin
9.75%
0.00%
0.00
9.75%
PAT Margin
4.00%
0.00%
0.00
4.00%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,604.60 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 14.27% vs -17.57% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 3.50% vs 6.03% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 64.20 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 96.33% vs -61.66% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 38.96% vs -26.90% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 162.60 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 109.54% vs -56.65% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 31.34% vs -28.36% in Jun 2025

Quarterly - Interest
Interest 10.40 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 1.96% vs 27.50% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 48.57% vs 84.21% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.06%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Footer loading